|
Market Closed -
OTC Markets
03:51:35 2026-09-18 pm EDT
|
5-day change | 1st Jan Change | ||
| 0.0225 USD | -2.17% |
|
-2.81% | -13.46% |
| May. 18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Nov. 17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.17% | -2.81% | -22.41% | -43.75% | -13.46% | -72.15% | -97.23% | -99.58% | -99.69% | 6.1M | |
| -0.58% | -1.06% | -2.62% | +29.10% | +1.68% | +34.05% | -4.68% | +20.40% | +92.07% | 78.83B | |
| -1.11% | +3.59% | +30.45% | +64.43% | +1.70% | -12.67% | -34.40% | -43.24% | +70.64% | 60.48B | |
| -2.55% | +12.75% | +138.97% | +149.26% | +422.35% | +516.16% | +34.43% | -64.18% | - | 63.11B | |
| +0.14% | -1.76% | -9.69% | +2.04% | -17.52% | -10.86% | +24.38% | -2.55% | - | 46.75B | |
| -0.24% | +3.17% | -3.39% | -17.55% | -12.78% | +2.51% | +147.15% | +125.46% | +183.21% | 45.66B | |
| -1.62% | +0.03% | +3.04% | +8.47% | +22.45% | +48.75% | -15.42% | -28.21% | -29.23% | 32.37B | |
| -1.81% | +1.65% | +1.47% | +26.59% | +26.87% | +47.77% | +100.34% | +64.90% | +52.54% | 25.87B | |
| +0.47% | +2.38% | +1.31% | +29.06% | +26.69% | +0.10% | +146.43% | +45.26% | - | 21.33B | |
| +0.27% | +1.87% | -2.36% | +1.50% | +34.31% | +63.02% | +99.38% | +86.17% | +339.10% | 15.8B | |
| -1.04% | -8.12% | -16.62% | -1.16% | -12.92% | +30.15% | +128.66% | +27.80% | - | 13.16B | |
| -0.20% | -8.48% | -19.27% | -11.65% | -26.69% | -30.33% | +403.13% | +394.33% | +5,509.36% | 12.81B | |
| -1.75% | -2.40% | -4.05% | +16.21% | +7.59% | +17.60% | -27.47% | -17.77% | -33.99% | 12.6B | |
| -3.03% | -1.58% | -3.93% | -17.60% | +13.76% | +78.17% | +176.08% | +599.13% | +2,726.94% | 11.22B | |
| -0.61% | -2.57% | +0.28% | -1.46% | +36.56% | +118.55% | +180.16% | +468.80% | - | 10.03B | |
| +7.35% | +31.64% | +34.23% | +101.51% | +426.45% | +519.17% | +697.09% | +37.17% | - | 9.75B | |
| -1.71% | -2.81% | -2.77% | +5.98% | -10.82% | -20.81% | -27.82% | -56.27% | -50.13% | 6.63B | |
| -0.33% | +1.52% | -7.15% | +27.42% | +1.23% | -5.20% | +55.59% | -12.27% | - | 6.14B | |
| -2.63% | +0.99% | -2.45% | +42.48% | +87.25% | +118.01% | +350.64% | +533.63% | - | 6.19B | |
| +0.37% | +2.69% | -17.03% | +4.39% | -1.47% | +9.90% | +189.57% | +194.95% | - | 5.39B | |
| Average | -0.52% | +2.26% | +4.80% | +20.76% | +50.66% | +72.59% | +126.30% | +113.70% | +796.44% | 24.21B | |
| Weighted average by Cap. | -0.50% | +3.39% | +19.69% | +36.81% | +67.65% | +94.78% | +71.91% | +50.67% | +417.10% |
- Stock Market
- Stocks
- ADAPY Stock
- Sector Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
